ResearcherThird Affiliated Hospital of Guangzhou Medical UniversityNo recent work listed

Jiao Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3286-8861; OpenAlex author ID A5100349709. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells. Last author DOI 10.1038/s41598-023-28261-4 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dongwen Que · 1 shared paper, 2023 · strength 0.24
- Paper ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells. DOI 10.1038/s41598-023-28261-4 ↗
Feimei Kuang · 1 shared paper, 2023 · strength 0.24
- Paper ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells. DOI 10.1038/s41598-023-28261-4 ↗
Rui Kang · 1 shared paper, 2023 · strength 0.24
- Paper ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells. DOI 10.1038/s41598-023-28261-4 ↗
Daolin Tang · 1 shared paper, 2023 · strength 0.24
- Paper ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells. DOI 10.1038/s41598-023-28261-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.